SCHEMBL170476

SCHEMBL170476

Cc1cc(C(C)(C(=O)OCCOCCOCCO)c2cc(C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
CHRM2 P08172 3/20 0.35
GAA P10253 2/20 0.35
GSR P00390 2/20 0.34
VCAM1 P19320 3/20 0.33
CHRM4 P08173 2/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
PKM P14618 1/20 0.33
HTT P42858 1/20 0.33
CHRM5 P08912 1/20 0.33
SERPINE1 P05121 1/20 0.33
GLRA3 O75311 1/20 0.33
GLRB P48167 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CA2 P00918 1/20 0.33
POLB P06746 1/20 0.33
TYR P14679 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29416252 1.00 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19CHRM2GAA
SCHEMBL17181577 1.00 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19CHRM2GAA
SCHEMBL29695404 1.00 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19CHRM2GAA
SCHEMBL3683437 0.93 GSR (0.39) CHRM2GAAGSRVCAM1HTT
SCHEMBL31501825 0.93 GSR (0.39) CHRM2GAAGSRVCAM1HTT
SCHEMBL2474150 0.92 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19CHRM2GAA
Ethylene SCHEMBL10704938 0.90 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19CHRM2GAA
Triethylene Glycol SCHEMBL170477 0.87 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19GAAGSR
SCHEMBL7080496 0.85 GSR (0.43) CYP1A2CYP2C9CYP2C19CHRM2GAA
SCHEMBL31360779 0.83 SMN1; SMN2 (0.47) CYP2C9CYP2C19GAAGSRVCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 715 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236100-A1 POLYMER STRUCTURE AND APPLICATIONS THEREOF CHITEC TECHNOLOGY CO., LTD. (TW) 2025-07-24 US claimed
EP-4506416-A1 THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PREPARING THERMOPLASTIC RESIN COMPOSITION AND USE OF PLASTIC FILM Chimei Corporation (TW) 2025-02-12 EP claimed
US-20250043129-A1 THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PREPARING THERMOPLASTIC RESIN COMPOSITION AND USE OF PLASTIC FILM CHIMEI CORPORATION (TW) 2025-02-06 US claimed
EP-4090710-B1 COATING COMPOSITIONS GKN AEROSPACE SERVICES LTD (GB) 2025-01-01 EP claimed
EP-4407008-A1 ANTI-FOG COATING AND PREPARATION METHOD THEREFOR, AND ANTI-FOG GLASS Fuyao Glass Industry Group Co., Ltd. (CN) 2024-07-31 EP claimed
EP-3632950-B1 STORAGE-STABLE HEAT-CURABLE HYBRID EPOXY FUNCTIONAL COMPOSITION AND TRANSPARENT HEAT-CURED COATINGS PREPARED THEREFROM ESSILOR INT (FR) 2024-07-17 EP claimed
US-20240191007-A1 SURFACE GRADIENT CROSS-LINKING METHOD OF ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE AND THE APPLICATION THEREOF B ONE MEDICAL SUZHOU CO LTD (CN) 2024-06-13 US claimed
US-20240174839-A1 STABILIZER MIXTURE BASF SE (DE) 2024-05-30 US claimed
US-11952439-B2 Surface gradient cross-linking method of ultra-high molecular weight polyethylene and the application thereof b-ONE Medical (Suzhou) Co., Ltd. (CN) 2024-04-09 US claimed
US-20240010836-A1 POLYAMIDE PARTS WITH LOW FUEL PERMEATION EMS-CHEMIE AG (CH) 2024-01-11 US claimed
EP-1549704-B1 STABILIZED POLYMER COMPOSITION BOREALIS TECH OY (FI) 2006-02-15 EP claimed
EP-1549704-A1 STABILIZED POLYMER COMPOSITION Borealis Technology Oy (FI) 2005-07-06 EP claimed
US-6806304-B2 OXIDATION RESISTANCE; DISCOLORATION INHIBITION CYTEC TECHNOLOGY CORP. 2004-10-19 US claimed
WO-2004033545-A1 STABILIZED POLYMER COMPOSITION BOREALIS TECHNOLOGY OY (FI) 2004-04-22 WO claimed
WO-2003035733-A1 PROCESS FOR IMPROVING THE SHELF LIFE OF A HINDERED PHENOL ANTIOXIDANT CYTEC TECHNOLOGY CORP. (US) 2003-05-01 WO claimed
US-20030073771-A1 Process for improving the shelf life of a hindered phenol antioxidant CYTEC TECHNOLOGY CORP. 2003-04-17 US claimed
EP-0114028-B1 COLOUR-PHOTOGRAPHIC RECORDING MATERIAL CIBA-GEIGY AG (CH) 1988-08-03 EP claimed
US-4517283-A STABILIZED BY POLYALKYLPIPERIDINE COMPOUND AND PHENOL ANTIOXIDANT CIBA-GEIGY AG (CH) 1985-05-14 US claimed
US-4477638-A Hindered phenolic esters of oligomeric glycols as chain terminators for polyvinyl chloride polymerization CIBA-GEIGY CORPORATION (US) 1984-10-16 US claimed
EP-0114028-A2 Colour-photographic recording material CIBA-GEIGY AG (CH) 1984-07-25 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240191007-A1 SURFACE GRADIENT CROSS-LINKING METHOD OF ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE AND THE APPLICATION THEREOF RPL7, PLAUR, CUTA CYP1A2 1213/4885CYP2C9 963/4885CYP2C19 990/4885
US-11952439-B2 Surface gradient cross-linking method of ultra-high molecular weight polyethylene and the application thereof RPL7, PLAUR, CUTA CYP1A2 1213/4885CYP2C9 963/4885CYP2C19 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.